אבקויר לאמיבודין תרו
taro international ltd, israel - abacavir; lamivudine - טבליות מצופות פילם - lamivudine 300 mg; abacavir 600 mg - lamivudine and abacavir
ארלוטיניב אס.קיי. 100 מג
k.s.kim international (sk- pharma) ltd., israel - erlotinib hydrochloride - טבליות מצופות פילם - erlotinib hydrochloride 100 mg - erlotinib
ארלוטיניב אס.קיי. 150 מג
k.s.kim international (sk- pharma) ltd., israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 150 mg - erlotinib
ארלוטיניב אס.קיי. 25 מג
k.s.kim international (sk- pharma) ltd., israel - erlotinib hydrochloride - טבליות מצופות פילם - erlotinib hydrochloride 25 mg - erlotinib
מידולם 1 מגמל
rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 1 mg/ml - midazolam - midazolam - premedication before induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration). status epilepticus.
מידולם 5 מגמל
rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 5 mg/ml - midazolam - midazolam - premedication befor induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration).status epilepticus.
cellculturemedia for ivf,art,et and sperm laboratories
דבורה חסון - מומחה
רסטזיס
abbvie biopharmaceuticals ltd, israel - ciclosporin - תחליב לעין - ciclosporin 0.05 % - cyclosporin - cyclosporin - to increase tear production in patients whose tear production is presumed to be supressed due to ocular inflammation associated with keratoconjunctivitis sicca. increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.